| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
National Cancer Institute-Navy Medical Oncology Branch, Naval Hospital, Bethesda, Maryland 20814-5105 [J-G. P., B. S. K., J. C., J. D. M., A. F. G.], and Biostatistics and Data Management Section, Clinical Oncology Program [S. M. S.] and Clinical Pharmacology Branch [J. M. C.], National Cancer Institute, Bethesda, Maryland 20892
The in vitro chemosensitivity of 11 human colorectal cell lines to seven chemotherapeutic agents was determined using a semiautomated tetrazolium-based colorimetric assay (MTT assay). Four of the cell lines were from primary tumors and seven from metastases. Eight lines were from patients with no prior chemotherapy. From assay results, we predict 5-fluorouracil (5-FU) to be the sole active agent of the seven tested. This is based on two observations: the range of drug concentrations which produced 50% inhibition of cell growth was greatest with 5-FU (388-fold versus 5- to 30-fold with the other six agents); and the area under the curve (AUC) which produced 50% growth inhibition was within a clinically achievable range only for 5-FU. Since the assay AUC of 5-FU at 50% inhibition was in a clinically achievable range for only two of the 11 cell lines, we performed a multivariate analysis to explore parameters which predict 5-FU sensitivity. In the best fitting model, sensitivity was positively correlated with cloning efficiency in media and with cell surface TAG-72 (a tumor-associated glycoprotein found on epithelial tumors of ovary, lung, colon, and breast origin) expression. If validated with an in vivo test such as the nude mouse model, the MTT assay could be very useful in new drug screening for colorectal carcinoma, for examining combination chemotherapy for synergy, for exploring strategies for biochemical modulation, and perhaps in individualizing therapy when cell lines can be established from a patient.
1 The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Navy or the Department of Defense.
2 To whom requests for reprints should be addressed, at Department of Surgery, College of Medicine, Seoul National University and Seoul National University Hospital, Seoul, 110, Korea.
3 Present address: Department of Clinical Oncology, Newcastle General Hospital, Newcastle, England.
Received 2/ 2/87. Revised 5/20/87. Accepted 8/ 3/87.
This article has been cited by other articles:
![]() |
T. Yoshimasu, S. Oura, I. Hirai, T. Tamaki, Y. Kokawa, K. Hata, F. Ohta, R. Nakamura, M. Kawago, H. Tanino, et al. Data acquisition for the histoculture drug response assay in lung cancer J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 303 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Bian, T. D. Giordano, H.-J. Lin, G. Solomon, V. P. Castle, and A. W. Opipari Jr. Chemotherapy-induced Apoptosis of S-type Neuroblastoma Cells Requires Caspase-9 and Is Augmented by CD95/Fas Stimulation J. Biol. Chem., February 6, 2004; 279(6): 4663 - 4669. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Welsh, R. R. Williams, A. Birmingham, D. J. Newman, D. L. Kirkpatrick, and G. Powis The Thioredoxin Redox Inhibitors 1-Methylpropyl 2-Imidazolyl Disulfide and Pleurotin Inhibit Hypoxia-induced Factor 1{alpha} and Vascular Endothelial Growth Factor Formation Mol. Cancer Ther., March 1, 2003; 2(3): 235 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jacob, M. Aguado, D. Fallik, and F. Praz The Role of the DNA Mismatch Repair System in the Cytotoxicity of the Topoisomerase Inhibitors Camptothecin and Etoposide to Human Colorectal Cancer Cells Cancer Res., September 1, 2001; 61(17): 6555 - 6562. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Shikhman, K. Kuhn, N. Alaaeddine, and M. Lotz N-Acetylglucosamine Prevents IL-1{{beta}}-Mediated Activation of Human Chondrocytes J. Immunol., April 15, 2001; 166(8): 5155 - 5160. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. van Triest, H. M. Pinedo, Y. van Hensbergen, K. Smid, F. Telleman, P. S. Schoenmakers, C. L. van der Wilt, J. A. M. van Laar, P. Noordhuis, G. Jansen, et al. Thymidylate Synthase Level as the Main Predictive Parameter for Sensitivity to 5-Fluorouracil, but not for Folate-based Thymidylate Synthase Inhibitors, in 13 Nonselected Colon Cancer Cell Lines Clin. Cancer Res., March 1, 1999; 5(3): 643 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Mccormick-Thomson, D. Sgouras, and R. Duncan Poly(amino acid) Copolymers as a Potential Soluble Drug Delivery System. 2. Body Distribution and Preliminary Biocompatibility Testing In Vitro and In Vivo Journal of Bioactive and Compatible Polymers, January 1, 1989; 4(3): 252 - 268. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |